Log in to save to my catalogue

Extended dual antithrombotic therapy in patients with chronic coronary syndrome - which agent should...

Extended dual antithrombotic therapy in patients with chronic coronary syndrome - which agent should...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_3206595433

Publication information

Publisher

Poland

More information

Scope and Contents

Contents

According to the 2024ESC Guidelines for the management of chronic coronary syndromes dual antithrombotic treatment comprising aspirin and a second antithrombotic drug for extended long-term prevention should be considered in patients at increased ischemic risk without high bleeding risk. However, no clear indications regarding the choice of a secon...

Alternative Titles

Full title

Extended dual antithrombotic therapy in patients with chronic coronary syndrome - which agent should be added to aspirin?

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_3206595433

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_3206595433

Other Identifiers

ISSN

1897-5593,1898-018X

E-ISSN

1898-018X

DOI

10.5603/cj.104821

How to access this item